Atlas Trials

Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?

Clinical trial NCT04623385 · UNKNOWN

Trial details

NCT number
NCT04623385
Sponsor
Kafrelsheikh University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Covid19
Start date
2020-11-01
Primary completion
2020-12-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.